Globe Newswire01.08.18
Integer Holdings Corporation, a medical device outsource (MDO) manufacturer announced that its subsidiary, Centro de Construccion de Cardioestimuladores del Uruguay S.A. (CCC), has signed a 10-year supply agreement with Neuros Medical Inc. Under the new agreement, CCC will be the sole supplier of key products for Neuros’ Altius System. The products include the implantable generator and related external devices (Clinician Programming Wand, Patient Controller, and Charger).
Neuros is currently conducting a pivotal investigational device exemption clinical study to evaluate its patented Altius System High Frequency Nerve Block technology for the management of post-amputation pain (including post-amputation pain, phantom limb-pain, residual limb pain, and stump pain).
“We are honored to be awarded this long-term supply agreement with Neuros, a company that shares our vision to enhance the lives of patients worldwide through life-changing technology,” said Tony Gonzalez, president of Integer’s Cardiac Rhythm Management and Neuromodulation product line. “This agreement highlights Integer’s breadth of capabilities to support customers with design, development and manufacturing of advanced technologies and systems. By leveraging our fully customizable platforms and our systems expertise, we will help Neuros bring its therapy to market quickly and cost-effectively, while maintaining the utmost quality and reliability. We look forward to continuing our relationship with the Neuros team as they progress through their current clinical study and beyond.”
Tom Wilder, Neuros Medical’s president and CEO, said, “We are excited to have Integer as a strategic partner and supplier in our long-term plans to utilize our High Frequency Nerve Block technology to address unmet medical needs involving chronic nerve pain. This includes continued enrollment in and completion of our pivotal IDE clinical study to investigate the use of the Altius System for treatment of post-amputation pain.”
Integer Holdings Corporation is one of the world's largest medical device outsource (MDO) manufacturers, serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. The company provides technologies and manufacturing to medical device OEMs. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. The company's brands include Greatbatch Medical, Lake Region Medical and Electrochem.
Neuros Medical Inc. is a neuromodulation company developing proprietary therapies for unmet needs. The company’s patented platform technology, the Altius High Frequency Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of conditions, including amputation pain, post-surgical pain, migraine, and trigeminal neuralgia. The Neuros Altius System consists of an implantable generator with an integrated rechargeable battery, cuff electrode, and external devices (Clinician Programming Wand, Patient Controller and Charger).
The Altius System High Frequency Nerve Block is an Investigational device and limited by U.S. law to investigational use.
Neuros is currently conducting a pivotal investigational device exemption clinical study to evaluate its patented Altius System High Frequency Nerve Block technology for the management of post-amputation pain (including post-amputation pain, phantom limb-pain, residual limb pain, and stump pain).
“We are honored to be awarded this long-term supply agreement with Neuros, a company that shares our vision to enhance the lives of patients worldwide through life-changing technology,” said Tony Gonzalez, president of Integer’s Cardiac Rhythm Management and Neuromodulation product line. “This agreement highlights Integer’s breadth of capabilities to support customers with design, development and manufacturing of advanced technologies and systems. By leveraging our fully customizable platforms and our systems expertise, we will help Neuros bring its therapy to market quickly and cost-effectively, while maintaining the utmost quality and reliability. We look forward to continuing our relationship with the Neuros team as they progress through their current clinical study and beyond.”
Tom Wilder, Neuros Medical’s president and CEO, said, “We are excited to have Integer as a strategic partner and supplier in our long-term plans to utilize our High Frequency Nerve Block technology to address unmet medical needs involving chronic nerve pain. This includes continued enrollment in and completion of our pivotal IDE clinical study to investigate the use of the Altius System for treatment of post-amputation pain.”
Integer Holdings Corporation is one of the world's largest medical device outsource (MDO) manufacturers, serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. The company provides technologies and manufacturing to medical device OEMs. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. The company's brands include Greatbatch Medical, Lake Region Medical and Electrochem.
Neuros Medical Inc. is a neuromodulation company developing proprietary therapies for unmet needs. The company’s patented platform technology, the Altius High Frequency Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of conditions, including amputation pain, post-surgical pain, migraine, and trigeminal neuralgia. The Neuros Altius System consists of an implantable generator with an integrated rechargeable battery, cuff electrode, and external devices (Clinician Programming Wand, Patient Controller and Charger).
The Altius System High Frequency Nerve Block is an Investigational device and limited by U.S. law to investigational use.
